JERRY N PRUITT
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology AUGUSTA, GA NPI 1316047871
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology GA ABBVIE INC. All categories
General Payments — all program years on this page
$11,056.64
- Category: General Payments
- Program years: PY2018–2024
- Record count: 547
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,880.22 across 87 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,880.22 | 87 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $374.38 | 27 |
| PFIZER INC. | $268.04 | 14 |
| Lundbeck LLC | $188.88 | 7 |
| ARGENX US, INC. | $179.32 | 6 |
| Alexion Pharmaceuticals, Inc. | $175.00 | 4 |
| Teva Pharmaceuticals USA, Inc. | $145.63 | 3 |
| UCB, Inc. | $98.74 | 4 |
| Acerta Pharma LLC | $83.32 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $80.56 | 4 |
| Novo Nordisk AS | $69.79 | 3 |
| Lilly USA, LLC | $64.22 | 4 |
| SCILEX PHARMACEUTICALS INC. | $43.28 | 2 |
| CSL Behring | $28.86 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $23.72 | 1 |
| Neurocrine BioSciences, Inc. | $19.88 | 1 |
| Dynavax Technologies Corporation | $19.78 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.82 | 1 |
By program year
Records — PY2024 (87)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.